New Delhi, Nov. 14 -- The sell-off in Cohance Lifesciences deepened further in Friday's trading session, with the stock crashing another 2.2% to Rs.615 apiece, the lowest level since June 2024. This extended its losing streak to the 12th consecutive trading session, leading to a cumulative drop of 28.40%, which is also its biggest sustained crash in recent times.

The decline began in late October after the company's Managing Director and director, V. Prasada Raju, resigned from his role, which was further compounded by the company's weak performance in the September quarter.

The relentless crash in the stock has also resulted in huge losses for domestic mutual funds. At the end of the September quarter, 30 mutual funds collectively owne...